Ami Asset Management Corp Biogen Inc. Transaction History

Ami Asset Management Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 25, 2019	SELL	$216.71 - $338.96 $16.8 Million - $26.3 Million	-77,696 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$278.5 - $352.75 $1.49 Million - $1.89 Million	-5,346 Reduced 6.44%	77,696 $23.4 Million
Q3 2018 Oct 23, 2018	SELL	$293.51 - $383.83 $420,599 - $550,028	-1,433 Reduced 1.7%	83,042 $29.3 Million
Q2 2018 Jul 23, 2018	SELL	$257.52 - $306.91 $608,004 - $724,614	-2,361 Reduced 2.72%	84,475 $24.5 Million
Q1 2018 Apr 20, 2018	SELL	$260.13 - $367.91 $463,291 - $655,247	-1,781 Reduced 2.01%	86,836 $23.8 Million
Q4 2017 Jan 16, 2018	SELL	$307.64 - $344.58 $1.06 Million - $1.19 Million	-3,457 Reduced 3.75%	88,617 $28.2 Million
Q3 2017 Oct 10, 2017	BUY	$281.15 - $329.69 $25.9 Million - $30.4 Million	92,074	92,074 $28.8 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Ami Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Ami Asset Management Corp with notifications on news.